Cargando…

Preliminary verification of the anti-hypoxia mechanism of Gentiana straminea maxim based on UPLC-triple TOF MS/MS and network pharmacology

BACKGROUND: Anoxia is characterized by changes in the morphology, metabolism, and function of tissues and organs due to insufficient oxygen supply or oxygen dysfunction. Gentiana straminea Maxim (G.s Maxim) is a traditional Tibetan medicine. Our previous work found that G.s Maxim mediates resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Xiu mei, Song, Dan, Li, Jie, Jiang, Yi, Zhang, Xiao ying, Wu, Xiao Jun, Ge, Ming juan, Xu, Jiao jiao, Gao, Xiao min, Zhao, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700950/
https://www.ncbi.nlm.nih.gov/pubmed/36434600
http://dx.doi.org/10.1186/s12906-022-03773-0
_version_ 1784839429856165888
author Kong, Xiu mei
Song, Dan
Li, Jie
Jiang, Yi
Zhang, Xiao ying
Wu, Xiao Jun
Ge, Ming juan
Xu, Jiao jiao
Gao, Xiao min
Zhao, Qin
author_facet Kong, Xiu mei
Song, Dan
Li, Jie
Jiang, Yi
Zhang, Xiao ying
Wu, Xiao Jun
Ge, Ming juan
Xu, Jiao jiao
Gao, Xiao min
Zhao, Qin
author_sort Kong, Xiu mei
collection PubMed
description BACKGROUND: Anoxia is characterized by changes in the morphology, metabolism, and function of tissues and organs due to insufficient oxygen supply or oxygen dysfunction. Gentiana straminea Maxim (G.s Maxim) is a traditional Tibetan medicine. Our previous work found that G.s Maxim mediates resistance to hypoxia, and we found that the ethyl acetate extract had the best effect. Nevertheless, the primary anti-hypoxia components and mechanisms of action remain unclear. METHODS: Compounds from the ethyl acetate extraction of G.s Maxim were identified using UPLC-Triple TOF MS/MS. Then Traditional Chinese Medicine Systematic Pharmacology Database was used to filtrate them. Network pharmacology was used to forecast the mechanisms of these compounds. Male specific pathogen-free Sprague Dawley rats were randomly divided into six groups: (1) Control; (2) Model; (3) 228 mg/kg body weight Rhodiola capsules; (4) 6.66 g/kg body weight the G.s Maxim’s ethyl acetate extraction; (5) 3.33 g/kg body weight the G.s Maxim’s ethyl acetate extraction; (6) 1.67 g/kg body weight the G.s Maxim’s ethyl acetate extraction. After administering intragastric ally for 15 consecutive days, an anoxia model was established using a hypobaric oxygen chamber (7000 m, 24 h). Then Histology, enzyme-linked immunosorbent assays, and western blots were performed to determine these compounds’ anti-hypoxic effects and mechanisms. Finally, we performed a molecular docking test to test these compounds using Auto Dock. RESULTS: Eight drug-like compounds in G.s Maxim were confirmed using UPLC-Triple TOF MS/MS and Lipinski’s rule. The tumor necrosis factor (TNF) signaling pathway, the hypoxia-inducible factor 1 (HIF-1) signaling pathway, and the nuclear factor kappa-B (NF-κB) signaling pathway was signaling pathways that G.s Maxim mediated anti-anoxia effects. The critical targets were TNF, Jun proto-oncogene (JUN), tumor protein p53 (TP53), and threonine kinase 1 (AKT1). Animal experiments showed that the ethyl acetate extraction of G.s Maxim ameliorated the hypoxia-induced damage of hippocampal nerve cells in the CA1 region and reversed elevated serum expression of TNF-α, IL-6, and NF-κ B in hypoxic rats. The compound also reduced the expression of HIF-1α and p65 and increased the Bcl-2/Bax ratio in brain tissue. These findings suggest that G.s Maxim significantly protects against brain tissue damage in hypoxic rats by suppressing hypoxia-induced apoptosis and inflammation. Ccorosolic acid, oleanolic acid, and ursolic acid had a strong affinity with core targets. CONCLUSIONS: The ethyl acetate extraction of G.s Maxim mediates anti-hypoxic effects, possibly related to inhibiting apoptosis and inflammatory responses through the HIF-1/NF-κB pathway. The primary active components might be corosolic, oleanolic, and ursolic acids. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-022-03773-0.
format Online
Article
Text
id pubmed-9700950
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97009502022-11-27 Preliminary verification of the anti-hypoxia mechanism of Gentiana straminea maxim based on UPLC-triple TOF MS/MS and network pharmacology Kong, Xiu mei Song, Dan Li, Jie Jiang, Yi Zhang, Xiao ying Wu, Xiao Jun Ge, Ming juan Xu, Jiao jiao Gao, Xiao min Zhao, Qin BMC Complement Med Ther Research BACKGROUND: Anoxia is characterized by changes in the morphology, metabolism, and function of tissues and organs due to insufficient oxygen supply or oxygen dysfunction. Gentiana straminea Maxim (G.s Maxim) is a traditional Tibetan medicine. Our previous work found that G.s Maxim mediates resistance to hypoxia, and we found that the ethyl acetate extract had the best effect. Nevertheless, the primary anti-hypoxia components and mechanisms of action remain unclear. METHODS: Compounds from the ethyl acetate extraction of G.s Maxim were identified using UPLC-Triple TOF MS/MS. Then Traditional Chinese Medicine Systematic Pharmacology Database was used to filtrate them. Network pharmacology was used to forecast the mechanisms of these compounds. Male specific pathogen-free Sprague Dawley rats were randomly divided into six groups: (1) Control; (2) Model; (3) 228 mg/kg body weight Rhodiola capsules; (4) 6.66 g/kg body weight the G.s Maxim’s ethyl acetate extraction; (5) 3.33 g/kg body weight the G.s Maxim’s ethyl acetate extraction; (6) 1.67 g/kg body weight the G.s Maxim’s ethyl acetate extraction. After administering intragastric ally for 15 consecutive days, an anoxia model was established using a hypobaric oxygen chamber (7000 m, 24 h). Then Histology, enzyme-linked immunosorbent assays, and western blots were performed to determine these compounds’ anti-hypoxic effects and mechanisms. Finally, we performed a molecular docking test to test these compounds using Auto Dock. RESULTS: Eight drug-like compounds in G.s Maxim were confirmed using UPLC-Triple TOF MS/MS and Lipinski’s rule. The tumor necrosis factor (TNF) signaling pathway, the hypoxia-inducible factor 1 (HIF-1) signaling pathway, and the nuclear factor kappa-B (NF-κB) signaling pathway was signaling pathways that G.s Maxim mediated anti-anoxia effects. The critical targets were TNF, Jun proto-oncogene (JUN), tumor protein p53 (TP53), and threonine kinase 1 (AKT1). Animal experiments showed that the ethyl acetate extraction of G.s Maxim ameliorated the hypoxia-induced damage of hippocampal nerve cells in the CA1 region and reversed elevated serum expression of TNF-α, IL-6, and NF-κ B in hypoxic rats. The compound also reduced the expression of HIF-1α and p65 and increased the Bcl-2/Bax ratio in brain tissue. These findings suggest that G.s Maxim significantly protects against brain tissue damage in hypoxic rats by suppressing hypoxia-induced apoptosis and inflammation. Ccorosolic acid, oleanolic acid, and ursolic acid had a strong affinity with core targets. CONCLUSIONS: The ethyl acetate extraction of G.s Maxim mediates anti-hypoxic effects, possibly related to inhibiting apoptosis and inflammatory responses through the HIF-1/NF-κB pathway. The primary active components might be corosolic, oleanolic, and ursolic acids. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-022-03773-0. BioMed Central 2022-11-25 /pmc/articles/PMC9700950/ /pubmed/36434600 http://dx.doi.org/10.1186/s12906-022-03773-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kong, Xiu mei
Song, Dan
Li, Jie
Jiang, Yi
Zhang, Xiao ying
Wu, Xiao Jun
Ge, Ming juan
Xu, Jiao jiao
Gao, Xiao min
Zhao, Qin
Preliminary verification of the anti-hypoxia mechanism of Gentiana straminea maxim based on UPLC-triple TOF MS/MS and network pharmacology
title Preliminary verification of the anti-hypoxia mechanism of Gentiana straminea maxim based on UPLC-triple TOF MS/MS and network pharmacology
title_full Preliminary verification of the anti-hypoxia mechanism of Gentiana straminea maxim based on UPLC-triple TOF MS/MS and network pharmacology
title_fullStr Preliminary verification of the anti-hypoxia mechanism of Gentiana straminea maxim based on UPLC-triple TOF MS/MS and network pharmacology
title_full_unstemmed Preliminary verification of the anti-hypoxia mechanism of Gentiana straminea maxim based on UPLC-triple TOF MS/MS and network pharmacology
title_short Preliminary verification of the anti-hypoxia mechanism of Gentiana straminea maxim based on UPLC-triple TOF MS/MS and network pharmacology
title_sort preliminary verification of the anti-hypoxia mechanism of gentiana straminea maxim based on uplc-triple tof ms/ms and network pharmacology
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700950/
https://www.ncbi.nlm.nih.gov/pubmed/36434600
http://dx.doi.org/10.1186/s12906-022-03773-0
work_keys_str_mv AT kongxiumei preliminaryverificationoftheantihypoxiamechanismofgentianastramineamaximbasedonuplctripletofmsmsandnetworkpharmacology
AT songdan preliminaryverificationoftheantihypoxiamechanismofgentianastramineamaximbasedonuplctripletofmsmsandnetworkpharmacology
AT lijie preliminaryverificationoftheantihypoxiamechanismofgentianastramineamaximbasedonuplctripletofmsmsandnetworkpharmacology
AT jiangyi preliminaryverificationoftheantihypoxiamechanismofgentianastramineamaximbasedonuplctripletofmsmsandnetworkpharmacology
AT zhangxiaoying preliminaryverificationoftheantihypoxiamechanismofgentianastramineamaximbasedonuplctripletofmsmsandnetworkpharmacology
AT wuxiaojun preliminaryverificationoftheantihypoxiamechanismofgentianastramineamaximbasedonuplctripletofmsmsandnetworkpharmacology
AT gemingjuan preliminaryverificationoftheantihypoxiamechanismofgentianastramineamaximbasedonuplctripletofmsmsandnetworkpharmacology
AT xujiaojiao preliminaryverificationoftheantihypoxiamechanismofgentianastramineamaximbasedonuplctripletofmsmsandnetworkpharmacology
AT gaoxiaomin preliminaryverificationoftheantihypoxiamechanismofgentianastramineamaximbasedonuplctripletofmsmsandnetworkpharmacology
AT zhaoqin preliminaryverificationoftheantihypoxiamechanismofgentianastramineamaximbasedonuplctripletofmsmsandnetworkpharmacology